228 related articles for article (PubMed ID: 1667268)
1. Antitumor organometallics. II. Inhibitory effects of two diphenyl-antimony (III) dithiophosphorus derivatives on in vitro and in vivo Ehrlich ascites tumor.
Socaciu C; Bara A; Silvestru C; Haiduc I
In Vivo; 1991; 5(4):425-8. PubMed ID: 1667268
[TBL] [Abstract][Full Text] [Related]
2. Antitumor organometallics. I. Activity of some diphenyltin(IV) and diphenylantimony(III) derivatives on in vitro and in vivo Ehrlich ascites tumor.
Bara A; Socaciu C; Silvestru C; Haiduc I
Anticancer Res; 1991; 11(4):1651-5. PubMed ID: 1836124
[TBL] [Abstract][Full Text] [Related]
3. The first organoantimony(III) compounds possessing antitumor properties: diphenylantimony(III) derivatives of dithiophosphorus ligands.
Silvestru C; Socaciu C; Bara A; Haiduc I
Anticancer Res; 1990; 10(3):803-4. PubMed ID: 2369094
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, structure, electrochemistry and spectral characterization of (D-glucopyranose)-4-phenylthiosemicarbazide metal complexes and their antitumor activity against Ehrlich ascites carcinoma in Swiss albino mice.
Sathisha MP; Budagumpi S; Kulkarni NV; Kurdekar GS; Revankar VK; Pai KS
Eur J Med Chem; 2010 Jan; 45(1):106-13. PubMed ID: 19854545
[TBL] [Abstract][Full Text] [Related]
5. Chloroaceto hydroxamic acid as antitumor agent against Ehrlich ascites carcinoma in mice.
Sur P; Bag SP; Sur B; Khanam JA
Neoplasma; 1997; 44(3):197-201. PubMed ID: 9372863
[TBL] [Abstract][Full Text] [Related]
6. [Primary suspended cultures of tumor cells from transplantable ascites tumors as a model for the study of antitumor compounds].
Ivanitskii LP; Makukho LV
Vopr Onkol; 1973 May; 19(5):67-71. PubMed ID: 4714738
[No Abstract] [Full Text] [Related]
7. Antineoplastic and cytogenetic effects of chlorpromazine on human lymphocytes in vitro and on Ehrlich ascites tumor cells in vivo.
Lialiaris TS; Papachristou F; Mourelatos C; Simopoulou M
Anticancer Drugs; 2009 Sep; 20(8):746-51. PubMed ID: 19584706
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Hep2 and HeLa cell proliferation in vitro and EAC tumor growth in vivo by Lapemis curtus (Shaw 1802) venom.
Karthikeyan R; Karthigayan S; Sri Balasubashini M; Somasundaram ST; Balasubramanian T
Toxicon; 2008 Jan; 51(1):157-61. PubMed ID: 17936322
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of cytogenetic damage and of antineoplastic effect by caffeine in Ehrlich ascites tumor cells treated with cyclophosphamide in vivo.
Mourelatos D; Dozi-Vassiliades J; Kotsis A; Gourtsas C
Cancer Res; 1988 Mar; 48(5):1129-31. PubMed ID: 3342394
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro antitumor activity of new substituted thiopyrimidine acyclic nucleosides and their thioglycoside analogs.
El-Sayed WA; Rashad AE; Awad SM; Ali MM
Nucleosides Nucleotides Nucleic Acids; 2009 Apr; 28(4):261-74. PubMed ID: 20183580
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, anticancer, and cytotoxic activities of some mononuclear Ru(II) compounds.
Karki SS; Thota S; Darj SY; Balzarini J; De Clercq E
Bioorg Med Chem; 2007 Nov; 15(21):6632-41. PubMed ID: 17765549
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapeutic potential of two gallic acid derivative compounds from leaves of Casearia sylvestris Sw (Flacourtiaceae).
Da Silva SL; Chaar Jda S; Yano T
Eur J Pharmacol; 2009 Apr; 608(1-3):76-83. PubMed ID: 19222998
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effect of carboplatin combined with hyperthermia on Ehrlich-ascites tumor in vivo.
Mizuuchi H; Yoshiga K; Sakurai K; Tsumura M; Takada K
Anticancer Res; 1996; 16(1):381-7. PubMed ID: 8615640
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activities of newly synthesized 5-carbamoyl-1 H-imidazol-4yl 1-adamantanecarboxylate and 5-carbamoyl-1H-imidazol-4yl piperonylate.
Yoshida N; Kiyohara T; Fukui M; Atsumi T; Ogino S; Inaba M; Tsukagoshi S; Sakurai Y
Cancer Res; 1980 Oct; 40(10):3810-4. PubMed ID: 7438064
[TBL] [Abstract][Full Text] [Related]
15. Antitumor actions of imidazolyl-(4-oxoquinazolin-3(4H)-yl)-acetamides against Ehrlich Ascites Carcinoma.
Raghavendra NM; Gurubasavarajaswamy PM; Nagaranavile KS; Parameshwaran T
Arch Pharm Res; 2009 Mar; 32(3):431-6. PubMed ID: 19387588
[TBL] [Abstract][Full Text] [Related]
16. Antineoplastic activities of alpha-, beta-, and gamma-alkylaminopropiophenone derivatives in mice and in murine and human tissue culture cells.
Huang Y; Hall IH
Anticancer Res; 1996; 16(2):597-604. PubMed ID: 8687103
[TBL] [Abstract][Full Text] [Related]
17. [The effects of CHIP (Pt IV) on the cytokinetics of Ehrlich ascites carcinoma cells].
Cao J; Pan QC
Yao Xue Xue Bao; 1987 Feb; 22(2):93-7. PubMed ID: 3618242
[No Abstract] [Full Text] [Related]
18. Isothiazolopyrimidines--new group of anticancer agents. I.
MachoĊ Z; Wieczorek J; Mordarski M
Arch Immunol Ther Exp (Warsz); 1987; 35(5):599-607. PubMed ID: 3455649
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of trans-bis(salicylaldoximato)copper(II): a novel antiproliferative metal complex.
Elo HO; Lumme PO
Cancer Treat Rep; 1985 Sep; 69(9):1021-2. PubMed ID: 4028035
[TBL] [Abstract][Full Text] [Related]
20. Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.
Valadares MC; Ramos AL; Rehmann FJ; Sweeney NJ; Strohfeldt K; Tacke M; Queiroz ML
Eur J Pharmacol; 2006 Mar; 534(1-3):264-70. PubMed ID: 16513106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]